Purpose of the company: Research, development, manufacture, import, export, distribution, promotion, marketing, and sale of medical, pharmaceutical, and/or nutritional products and medical and surgical devices and instruments, as well as all other activities related thereto; provision of services related to the aforementioned activities; provision of strategic planning and support services for management; and consulting...
Adress: Erika-Mann-Str. 21 80636 MĂŒnchen Deutschland
Local court: 80333 MĂŒnchen
Register number: HRB107705
The average total assets of company Santen GmbH over the last 17 years is 10.916.699,48 âŹ.
The company Santen GmbH as of the reporting date 2023 a bank balance of approx. 0,00 âŹ. That is -100,00 % less than the average bank balance in the industry of companies with this total assets.
The equity ratio of Santen GmbH is 33,12 % in the year 2023. In total, that ist 4.454.382,18 âŹ.
The average absolute change in liquidity of the company Santen GmbH compared to the previous year amounts to 0,00 âŹ. That means that the liquidity of the company has increased or decreased by this amount per year on average.
The cash flow of the company Santen GmbH amounts to 0,00 ⏠in the year 2023.
The publication dates refer to the date on which the company published its annual financial statements in the company register. This information can provide important insights into the management of the company.
The information presented here comes from publicly accessible sources, in particular the Unternehmensregister, in which companies are obliged to disclose their annual financial statements (Sections 325 et seq. of the German Commercial Code (HGB)).
All key financial figures are based on the companies' published annual financial statements. The information is analysed automatically by Bonscore, without content processing or interpretation.
Please note that despite the utmost care, no guarantee can be given that the information provided is up-to-date, complete or correct.